HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.

The large majority of human immunodeficiency virus type 1 (HIV-1) markers of disease progression/severity previously identified have been associated with alterations in host genetic and immune responses, with few studies focused on viral genetic markers correlate with changes in disease severity. Th...

Full description

Bibliographic Details
Main Authors:	Michael R Nonnemacher, Vanessa Pirrone, Rui Feng, Brian Moldover, Shendra Passic, Benjamas Aiamkitsumrit, Will Dampier, Adam Wojno, Evelyn Kilareski, Brandon Blakey, Tse-Sheun Jade Ku, Sonia Shah, Neil T Sullivan, Jeffrey M Jacobson, Brian Wigdahl
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4839606?pdf=render

Similar Items

Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.
by: Benjamas Aiamkitsumrit, et al.
Published: (2014-01-01)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.
by: Will Dampier, et al.
Published: (2016-01-01)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015-12-01)

Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
by: Pirrone Vanessa, et al.
Published: (2012-01-01)

Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
by: Shah Sonia, et al.
Published: (2009-12-01)

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
by: M. Nonnemacher, et al.
Published: (2015-12-01)

Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site
by: Yujie Liu, et al.
Published: (2017-03-01)

Genetic variation continues to occur in well-controlled HIV-1-infected patients
by: W. Dampier, et al.
Published: (2015-12-01)

Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy
by: Will Dampier, et al.
Published: (2024-01-01)

Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals.
by: Ashley Azar, et al.
Published: (2016-01-01)

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

PP 1.43 – 00206 Evaluating integrated HIV-1 quasispecies using Near Full Length sequencing in ART-suppressed individuals in the Drexel CARES Cohort
by: M. Collins, et al.
Published: (2022-12-01)

PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy
by: R. Berman, et al.
Published: (2022-12-01)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017-12-01)

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
by: Satinder Dahiya, et al.
Published: (2014-01-01)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
by: Alexander G. Allen, et al.
Published: (2018-12-01)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
by: Monique E Maubert, et al.
Published: (2016-01-01)

HIV- Bidirectional Encoder Representations From Transformers: A Set of Pretrained Transformers for Accelerating HIV Deep Learning Tasks
by: Will Dampier, et al.
Published: (2022-05-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
by: Anupam Banerjee, et al.
Published: (2017-03-01)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01)

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
by: Michael R. Nonnemacher, et al.
Published: (2017-04-01)

Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort
by: M.R. Nonnemacher, et al.
Published: (2017-12-01)

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015-12-01)

Region-specific Distribution of HIV-1 LTR C/EBP Site II Configurations in Demented and Non-demented Patients
by: Gartner Suzanne, et al.
Published: (2005-12-01)

HIV-Quasipore: A Suite of HIV-1-Specific Nanopore Basecallers Designed to Enhance Viral Quasispecies Detection
by: Robert W. Link, et al.
Published: (2022-05-01)

The Presence of Mucin Increases the Anti-HIV-1 Activity of the Candidate Microbicide Polyethylene Hexamethylene Biguanide (PEHMB)
by: Rando Robert F, et al.
Published: (2005-12-01)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020-09-01)

Biomarkers of HIV Susceptibility and Disease Progression
by: Vanessa Pirrone, et al.
Published: (2014-12-01)

Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization
by: Ferrucci Adriano, et al.
Published: (2011-08-01)

Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
by: Alexander G. Allen, et al.
Published: (2023-04-01)

Mild cognitive impairment in a clinically latent HIV-1 patient population
by: K.N. Devlin, et al.
Published: (2015-12-01)

HIV-1 LTR Activity is Altered by Recruitment of Sp Transcription Factors During Monocytic Differentiation
by: Wigdahl Brian, et al.
Published: (2005-12-01)

Characterization of C/EBP Binding Sites Downstream of the Transcriptional Start Site in the HIV-1 LTR
by: Wigdahl Brian, et al.
Published: (2005-12-01)

Use of HIV-1 LTR Sequence Variants as Prognostic Indicators of HIV Dementia
by: Wigdahl Brian, et al.
Published: (2005-12-01)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019-12-01)

Altered recruitment of Sp isoforms to HIV-1 long terminal repeat between differentiated monoblastic cell lines and primary monocyte-derived macrophages
by: John J. McAllister, et al.
Published: (2022-11-01)

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy
by: Hager Mohamed, et al.
Published: (2023-01-01)